Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer

BACKGROUND: The low level of circulating tumor DNA (ctDNA) in the blood is a well-known challenge for the application of liquid biopsies in early-stage non-small cell lung cancer (NSCLC) management. Studies of metastatic NSCLC indicate that ctDNA levels are associated with tumor metabolic activity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334612/
https://www.ncbi.nlm.nih.gov/pubmed/37434111
http://dx.doi.org/10.1186/s12885-023-11147-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334612/
https://www.ncbi.nlm.nih.gov/pubmed/37434111
http://dx.doi.org/10.1186/s12885-023-11147-z

Ejemplares similares